Naloxone & COVID-19
As the COVID-19 pandemic has spread throughout our country, SAMHSA has received reports that some first responders and law enforcement officers have been more reluctant to administer naloxone due to fear of potentially contracting the coronavirus. Further, SAMHSA has received reports that law enforcement and emergency services management has, in some cases, discontinued the carrying of naloxone by responders. The decision to withhold this lifesaving drug is equivalent to withholding cardiopulmonary resuscitation (CPR) to an unresponsive person who may have had a heart attack. It is essential that naloxone continue to be administered during this time period.